HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Response to paclitaxel, gemcitabine, and cisplatin in renal medullary carcinoma.

AuthorsMoshe D Bell
JournalPediatric blood & cancer (Pediatr Blood Cancer) Vol. 47 Issue 2 Pg. 228 (Aug 2006) ISSN: 1545-5009 [Print] United States
PMID16514612 (Publication Type: Case Reports, Comment, Letter)
Chemical References
  • Deoxycytidine
  • Paclitaxel
  • Cisplatin
  • Gemcitabine
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carcinoma, Medullary (drug therapy)
  • Cisplatin (administration & dosage)
  • Deoxycytidine (administration & dosage, analogs & derivatives)
  • Fatal Outcome
  • Humans
  • Kidney Medulla
  • Kidney Neoplasms (drug therapy)
  • Male
  • Paclitaxel (administration & dosage)
  • Gemcitabine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: